litlas
Log inCreate account

Ola Nilsson

Active 1977–2025

135
Papers
21,666
Citations
86
h-index
128
i10-index

Citations

Citations per year for Ola Nilsson1979: 1 citations1980: 7 citations1981: 3 citations1982: 3 citations1983: 2 citations1984: 1 citations1985: 5 citations1986: 7 citations1987: 18 citations1988: 28 citations1989: 30 citations1990: 40 citations1991: 50 citations1992: 45 citations1993: 35 citations1994: 65 citations1995: 63 citations1996: 77 citations1997: 74 citations1998: 52 citations1999: 84 citations2000: 88 citations2001: 79 citations2002: 69 citations2003: 111 citations2004: 102 citations2005: 94 citations2006: 113 citations2007: 136 citations2008: 169 citations2009: 172 citations2010: 226 citations2011: 182 citations2012: 176 citations2013: 136 citations2014: 151 citations2015: 146 citations2016: 117 citations2017: 112 citations2018: 96 citations2019: 421 citations2020: 426 citations2021: 354 citations2022: 292 citations2023: 177 citations2024: 320 citations2025: 96 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,717 citing papers, 24.3% of this breakdownUnited Kingdom: 520 citing papers, 7.4% of this breakdownGermany: 487 citing papers, 6.9% of this breakdownSweden: 456 citing papers, 6.5% of this breakdownItaly: 431 citing papers, 6.1% of this breakdownChina: 382 citing papers, 5.4% of this breakdownFrance: 306 citing papers, 4.3% of this breakdownCanada: 286 citing papers, 4% of this breakdownNetherlands: 274 citing papers, 3.9% of this breakdownJapan: 220 citing papers, 3.1% of this breakdownSwitzerland: 160 citing papers, 2.3% of this breakdownAustralia: 156 citing papers, 2.2% of this breakdown
0%24.3%Other 23.6%

Institutions

Fields

  • Medicine65.9%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Neuroscience8.2%
  • Computer Science2.7%
  • Immunology and Microbiology1.9%
  • Engineering1.3%
  • Other3.3%

Topics

  • Neuroendocrine Tumor Research Advances7.5%
  • Lung Cancer Research Studies4.9%
  • Neuroblastoma Research and Treatments3.1%
  • Pancreatic and Hepatic Oncology Research2.2%
  • Nerve injury and regeneration1.4%
  • Neuroscience and Neuropharmacology Research1.4%
  • Other79.5%

Coauthors

All papers

Open in search
  1. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

    Authors: Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale - The Lancet 2019 cited by 367

  2. FGF23 and its role in X-linked hypophosphatemia-related morbidity

    Authors: Signe Sparre Beck‐Nielsen, Zulf Mughal, Dieter Haffner, Ola Nilsson, Elena Levtchenko, Gema Ariceta, Carmen de Lucas Collantes, Dirk Schnabel, Ravi Jandhyala, Outi Mäkitie - Orphanet Journal of Rare Diseases 2019 cited by 277

  3. Gastroenteropancreatic neuroendocrine tumours

    Authors: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 cited by 1,752

  4. HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice

    Authors: Elin M.V. Forsberg, Mattias F. Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Marco Donia, Inge Marie Svane, Ola Nilsson, Lars Ny, Lisa M. Nilsson, Jonas A. Nilsson - Cancer Research 2019 cited by 130

  5. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

    Authors: Guido Rindi, G. Klöppel, H. Alhman, Martyn Caplin, Anne Couvelard, Wouter W. de Herder, B. Erikssson, Alberto Falchetti, Massimo Falconi, Paul Komminoth, Meike Körner, José Manuel Lopes, A. M. McNicol, Ola Nilsson, Aurel Perren, Aldo Scarpa, J-Y. Scoazec, Bertram Wiedenmann, and all other Frascati Consensus Conference participants - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2006 cited by 1,572

  6. Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Adult Hippocampus and Induces Progenitor Cell Proliferation

    Authors: Jenny Nyberg, Michelle F. Anderson, Björn Meister, Ann‐Marie Alborn, Anna-Karin Ström, Anke Brederlau, Ann-Christin Illerskog, Ola Nilsson, Timothy J. Kieffer, Max Albert Hietala, Anne Ricksten, Peter S. Eriksson - Journal of Neuroscience 2005 cited by 187

  7. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

    Authors: Leanne M. Ward, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Anthony A. Portale, Wolfgang Högler, Jill H. Simmons, Gary S. Gottesman, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Ola Nilsson, Meng Mao, Angel Chen, Alison Skrinar, Mary Scott Roberts, Erik A. Imel - The Journal of Clinical Endocrinology & Metabolism 2022 cited by 76

  8. Short and tall stature: a new paradigm emerges

    Authors: Jeffrey Baron, Lars Sävendahl, Francesco De Luca, Andrew Dauber, Moshe Phillip, Jan M. Wit, Ola Nilsson - Nature Reviews Endocrinology 2015 cited by 319

  9. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response

    Authors: Mattias K. Andersson, Anders Ståhlberg, Yvonne Arvidsson, Anita Olofsson, Henrik Semb, Göran Stenman, Ola Nilsson, Pierre Åman - BMC Cell Biology 2008 cited by 339

  10. The gut as the largest endocrine organ in the body

    Authors: H. Ahlman, Ola Nilsson - Annals of Oncology 2001 cited by 254

  11. GWAS for autoimmune Addison’s disease identifies multiple risk loci and highlights AIRE in disease susceptibility

    Authors: Daniel Eriksson, Ellen C. Røyrvik, Maribel Aranda‐Guillén, Amund Holte Berger, Nils Landegren, Haydeé Artaza, Åsa Hallgren, Marianne Aardal Grytaas, Sara S. Strom, Eirik Bratland, Ileana Ruxandra Botusan, Bergithe E Oftedal, Lars Breivik, Marc Vaudel, Øyvind Helgeland, Alberto Falorni, Anders Palmstrøm Jørgensen, Anna‐Lena Hulting, Johan Svartberg, Olov Ekwall, Kristian J. Fougner, Jeanette Wahlberg, Bjørn Gunnar Nedrebø, Per Dahlqvist, The Norwegian Addison Registry Study Group, Helge Ræder, Nevena Jovanovic, Sigfrid Christine Reisegg, Geir Hølleland, Siri Carlsen, Tore Julsrud Berg, Jan Bertil Eggesbø, Thomas Svendsen, Kari Lima, Ingrid Nermoen, Rolf Whitfield, Stina Therese Sollid, Dagfinn Aarskog, Elin Korsgaard, Solveig Sæta, Trine Finnes, Susanna F Valland, Caroline Fossum, Eli Brevik, Ragnar Bekkhus Moe, Margrethe Svendsen, Aleksandra Dębowska, Petya Milova, Synnøve Emblem Holte, Aneta Eva Tomkowicz, Dag Eirik Sørmo, Anders Svare, Marthe Landsverk Rensvik, Randi Revheim, T. Haug, Ivar Blix, Lars Petter Jensen, The Swedish Addison Registry Study Group, Anna‐Karin Åkerman, Anna‐Lena Hulting, Bengt Lindberg, Berit Kriström, Erik Waldenström, Gudmundur Johannsson, Jakob Skov, Jeanette Wahlberg, Karel Duchén, Magnus Isaksson, Maria Elfving, Maria Halldin Stenlid, Ola Nilsson, Olle Kämpe, Olov Ekwall, Per Dahlqvist, Ragnhildur Bergthorsdottir, Ricard Nergårdh, Sigríður Björnsdóttir, Sophie Bensing, Tommy Olsson, Per M. Knappskog, Anette S. B. Wolff, Sophie Bensing, Stefan Johansson, Olle Kämpe, Eystein S. Husebye - Nature Communications 2021 cited by 82

  12. Fibroblast growth factor expression in the postnatal growth plate

    Authors: Jacob E. Lazarus, Anita Hegde, Anenisia C. Andrade, Ola Nilsson, Jeffrey Baron - Bone 2006 cited by 127

  13. Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia

    Authors: Raja Padidela, Michael P. Whyte, Francis H. Glorieux, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Anthony A. Portale, Jill H. Simmons, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Angela Williams, Annabel Nixon, Wei Sun, Angel Chen, Alison Skrinar, Erik A. Imel - Calcified Tissue International 2021 cited by 48

  14. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

    Authors: Guido Rindi, Günter Klöppel, Anne Couvelard, Paul Komminoth, Meike Körner, José Manuel Lopes, A. M. McNicol, Ola Nilsson, Aurel Perren, Aldo Scarpa, Jean‐Yves Scoazec, Bertram Wiedenmann - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2007 cited by 954

  15. Endocrine Regulation of the Growth Plate

    Authors: Ola Nilsson, Rose Marino, Francesco De Luca, Moshe Phillip, Jeffrey Baron - Hormone Research in Paediatrics 2005 cited by 440

  16. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5

    Authors: Snævar Sigurðsson, Gunnel Nordmark, Sophie Garnier, Elin Grundberg, Tony Kwan, Ola Nilsson, Maija‐Leena Eloranta, Iva Gunnarsson, Elisabet Svenungsson, Gunnar Sturfelt, Anders Bengtsson, Andreas Jönsen, Lennart Truedsson, Solbritt Rantapää‐Dahlqvist, Catharina Eriksson, G. Alm, H.H.H. Göring, Tomi Pastinen, A-C Syvänen, L. Ronnblom - Human Molecular Genetics 2008 cited by 214

  17. Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations

    Authors: Ola Nilsson, Michael H. Guo, Nancy Dunbar, Jadranka Popovic, Daniel Flynn, Christina M. Jacobsen, Julian C. Lui, Joel N. Hirschhorn, Jeffrey Baron, Andrew Dauber - The Journal of Clinical Endocrinology & Metabolism 2014 cited by 137

  18. Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations

    Authors: Alexandra Gkourogianni, Melissa Andrew, Leah Tyzinski, Melissa K. Crocker, Jessica Douglas, Nancy Dunbar, Jan Fairchild, Mariana F.A. Funari, Karen E. Heath, Alexander A.L. Jorge, Tracey Kurtzman, Stephen LaFranchi, Seema R. Lalani, Jan Lebl, Yuezhen Lin, Evan Los, Dorothee Newbern, C. Nowak, Micah L. Olson, Jadranka Popovic, Štěpánka Průhová, Lenka Elblová, Jose Bernardo Quintos, Emma Segerlund, Lucia Sentchordi, Marwan Shinawi, Eva-Lena Stattin, Jonathan M. Swartz, Ariadna González del Ángel, Sinhué Diaz Cuéllar, Hidekazu Hosono, Pedro A. Sanchez‐Lara, Vivian Hwa, Jeffrey Baron, Ola Nilsson, Andrew Dauber - The Journal of Clinical Endocrinology & Metabolism 2016 cited by 135

  19. The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

    Authors: Gema Ariceta, Signe Sparre Beck‐Nielsen, Annemieke M. Boot, Maria Luisa Brandi, Karine Briot, Carmen de Lucas Collantes, Francesco Emma, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, Outi Mäkitie, M.Z. Mughal, Ola Nilsson, Dirk Schnabel, Liana Tripto‐Shkolnik, Jonathan Liu, Angela Williams, Sue Wood, M. Carola Zillikens - Orphanet Journal of Rare Diseases 2023 cited by 50

  20. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

    Authors: Hans Lilja, Anders Christensson, Ulrika Dahlén, Martti Matikainen, Ola Nilsson, Kim Pettersson, Timo Lövgren - Clinical Chemistry 1991 cited by 932

  21. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study

    Authors: Jan Hillman, Steen Friðriksson, Ola Nilsson, Zhengquan Yu, Hans Säveland, Karl‐Erik Jakobsson - Journal of neurosurgery 2002 cited by 393

  22. Clinical utility of biochemical markers in colorectal cancer

    Authors: Michael J. Duffy, A. van Dalen, Caj Haglund, Lars‐Erik Hansson, R Klapdor, R. Lamerz, Ola Nilsson, C. Sturgeon, Ondřej Topolčan - European Journal of Cancer 2003 cited by 372

  23. EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy

    Authors: Julian C. Lui, Presley Garrison, Quang Tri Nguyen, Michal Ad, Chithra Keembiyehetty, Weiping Chen, Youn Hee Jee, Ellie Landman, Ola Nilsson, Kevin M. Barnes, Jeffrey Baron - Nature Communications 2016 cited by 103

  24. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

    Authors: Raja Padidela, Ola Nilsson, Outi Mäkitie, Signe Sparre Beck‐Nielsen, Gema Ariceta, Dirk Schnabel, Maria Luisa Brandi, Annemieke M. Boot, Elena Levtchenko, Michael Smyth, Ravi Jandhyala, Zulf Mughal - Orphanet Journal of Rare Diseases 2020 cited by 48